Loxapine Articles
FDA advisory panel backs Alexza antipsychotic drug
15 December 2011
Alexza starts Ph III loxapine trial
3 March 2008
Alexza gets $50M investment for R&D
11 December 2006
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
